Amlodipine-folic Acid
AssetAlso amlodipine-FA
Combines calcium-channel blockade to lower blood pressure with folate supplementation to reduce homocysteine.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- CACNA1C
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Essential hypertension
Phase 2, Unknown, NCT01848873, clinicaltrials.gov, 15 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials1
- Evidence for its targets1
- Competitors9
Every asset’s record: target, stage, trials and the evidence behind it.